1. Home
  2. FMBH vs CRVS Comparison

FMBH vs CRVS Comparison

Compare FMBH & CRVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First Mid Bancshares Inc.

FMBH

First Mid Bancshares Inc.

HOLD

Current Price

$43.55

Market Cap

1.1B

Sector

Finance

ML Signal

HOLD

Logo Corvus Pharmaceuticals Inc.

CRVS

Corvus Pharmaceuticals Inc.

HOLD

Current Price

$16.83

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FMBH
CRVS
Founded
1865
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.2B
IPO Year
1995
2016

Fundamental Metrics

Financial Performance
Metric
FMBH
CRVS
Price
$43.55
$16.83
Analyst Decision
Hold
Strong Buy
Analyst Count
5
6
Target Price
$43.40
$30.17
AVG Volume (30 Days)
103.6K
948.2K
Earning Date
04-24-2026
05-07-2026
Dividend Yield
2.30%
N/A
EPS Growth
16.06
48.04
EPS
3.83
N/A
Revenue
N/A
N/A
Revenue This Year
$9.30
N/A
Revenue Next Year
$6.66
N/A
P/E Ratio
$11.37
N/A
Revenue Growth
N/A
N/A
52 Week Low
$32.62
$3.17
52 Week High
$44.85
$26.95

Technical Indicators

Market Signals
Indicator
FMBH
CRVS
Relative Strength Index (RSI) 60.42 58.92
Support Level $42.05 $16.15
Resistance Level $44.46 $18.73
Average True Range (ATR) 0.82 0.94
MACD 0.10 0.29
Stochastic Oscillator 66.15 87.73

Price Performance

Historical Comparison
FMBH
CRVS

About FMBH First Mid Bancshares Inc.

First Mid Bancshares Inc is a United States based financial holding company. Through its wholly-owned subsidiary, First Mid Bank, it is engaged in the business of banking. The company offers trust, farm services, investment services, and retirement planning through its wholly owned subsidiary, it also provides data processing services to affiliates and insurance products and services to customers through its subsidiary. The company's operations cover community banking, wealth management and insurance services. Key revenue is derived from the provision of community banking services.

About CRVS Corvus Pharmaceuticals Inc.

Corvus Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. It believes its proprietary product candidates have broad potential to address immune mediated diseases, inflammatory diseases and cancers. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The company operates in one primary business activity and operate as one reportable segment.

Share on Social Networks: